Embryo maternal dialogue: From pregnancy recognition to proliferation control

Area of Science:

• Reproductive Biology
• Immunology
• Developmental Biology

Background:

• Embryo-maternal communication is vital for pregnancy success, involving complex signaling pathways.
• The early embryo, a semi-allograft, must be tolerated by the maternal immune system.
• Control of embryonic cell proliferation and differentiation is critical for normal development.

Purpose of the Study:

• To identify novel embryo-derived signaling molecules involved in early pregnancy.
• To elucidate the role of these factors in modulating maternal immunity and endometrial receptivity.
• To investigate the function of newly identified proteins in regulating embryonic cell proliferation and differentiation.

Main Methods:

• Detection of embryo-derived peptides in maternal serum during early pregnancy.
• Identification and characterization of novel embryonic proteins (developmental proteins).
• Analysis of the molecular mechanisms by which these factors regulate cell proliferation, differentiation, and apoptosis.

Main Results:

• Discovery of pre-implantation factors (PIF), peptides secreted early in development, modulating cellular immunity.
• Identification of developmental proteins (DPs) that balance pro- and anti-proliferative forces, controlling abnormal cell growth.
• DPs were shown to inhibit DNA synthesis and promote apoptosis, while PIF primes the endometrium for implantation.

Conclusions:

• PIF and DPs are key regulators of early embryonic development and maternal immune tolerance.
• These novel factors offer potential therapeutic targets for managing early pregnancy complications and proliferative disorders like cancer.
• Understanding embryo-derived signaling is crucial for advancing reproductive medicine and oncology.